Literature DB >> 23992920

Histopathological evidence that hippocampal atrophy following status epilepticus is a result of neuronal necrosis.

Gogi Kumar1, Sandeep Mittal, Shyam S Moudgil, William J Kupsky, Aashit K Shah.   

Abstract

Medial temporal lobe epilepsy is commonly associated with hippocampal atrophy on MRI and hippocampal sclerosis on histopathological examination of surgically-resected specimens. Likewise, it is well-established that prolonged seizures and status epilepticus can lead to hippocampal edema as noted on MRI. In this paper, the authors present an unusual patient with prolonged refractory status epilepticus, due to limbic encephalitis associated with anti-GAD antibody, who underwent palliative epilepsy surgery. Bilateral hippocampal edema was noted on preoperative MRI. Histologic evaluation confirmed presence of acute necrosis and neuronal loss in the left hippocampal formation. Follow-up MRI several months after surgery demonstrated severe atrophy of the contralateral right hippocampus. This is the first clear histopathological evidence that hippocampal atrophy following status epilepticus is the result of acute neuronal necrosis and cell loss.
© 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anti-GAD antibody; Atrophy; Autoimmune encephalitis; Hippocampal necrosis; Hippocampal sclerosis; Limbic encephalitis; Refractory status epilepticus; Seizures

Mesh:

Year:  2013        PMID: 23992920     DOI: 10.1016/j.jns.2013.08.016

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  8 in total

1.  Silencing of P2X7R by RNA interference in the hippocampus can attenuate morphological and behavioral impact of pilocarpine-induced epilepsy.

Authors:  Rebeca Padrão Amorim; Michelle Gasparetti Leão Araújo; Jorge Valero; Iscia Lopes-Cendes; Vinicius Davila Bitencourt Pascoal; João Oliveira Malva; Maria José da Silva Fernandes
Journal:  Purinergic Signal       Date:  2017-07-13       Impact factor: 3.765

2.  Acute Resective Surgery for the Treatment of Refractory Status Epilepticus.

Authors:  Maysaa Merhi Basha; Kushak Suchdev; Monica Dhakar; William J Kupsky; Sandeep Mittal; Aashit K Shah
Journal:  Neurocrit Care       Date:  2017-12       Impact factor: 3.210

3.  Association of Progressive Cerebellar Atrophy With Long-term Outcome in Patients With Anti-N-Methyl-d-Aspartate Receptor Encephalitis.

Authors:  Takahiro Iizuka; Juntaro Kaneko; Naomi Tominaga; Hidehiro Someko; Masaaki Nakamura; Daisuke Ishima; Eiji Kitamura; Ray Masuda; Eiichi Oguni; Toshiyuki Yanagisawa; Naomi Kanazawa; Josep Dalmau; Kazutoshi Nishiyama
Journal:  JAMA Neurol       Date:  2016-06-01       Impact factor: 18.302

Review 4.  Review: Hippocampal sclerosis in epilepsy: a neuropathology review.

Authors:  Maria Thom
Journal:  Neuropathol Appl Neurobiol       Date:  2014-08       Impact factor: 8.090

5.  NLRP1 inflammasome is activated in patients with medial temporal lobe epilepsy and contributes to neuronal pyroptosis in amygdala kindling-induced rat model.

Authors:  Chen-Chen Tan; Jian-Guo Zhang; Meng-Shan Tan; Hua Chen; Da-Wei Meng; Teng Jiang; Xiang-Fei Meng; Ying Li; Zhen Sun; Meng-Meng Li; Jin-Tai Yu; Lan Tan
Journal:  J Neuroinflammation       Date:  2015-01-28       Impact factor: 8.322

6.  Thymoquinone Attenuates Brain Injury via an Anti-oxidative Pathway in a Status Epilepticus Rat Model.

Authors:  Yi-Ye Shao; Bing Li; Yong-Mei Huang; Qiong Luo; Yang-Mei Xie; Ying-Hui Chen
Journal:  Transl Neurosci       Date:  2017-03-25       Impact factor: 1.757

7.  Hippocampal Damage and Atrophy Secondary to Status Epilepticus in a Patient with Schizophrenia.

Authors:  Elaine Keiko Fujisao; Nathalia Raquel Cristaldo; Aline Marques da Silva Braga; Paulina Rodrigues Cunha; Seizo Yamashita; Luiz Eduardo Betting
Journal:  Front Neurol       Date:  2017-02-06       Impact factor: 4.003

Review 8.  Updates in Refractory Status Epilepticus.

Authors:  Rohit Marawar; Maysaa Basha; Advait Mahulikar; Aaron Desai; Kushak Suchdev; Aashit Shah
Journal:  Crit Care Res Pract       Date:  2018-05-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.